CN105434589A - Anti-fibrosis heart protecting decoction - Google Patents
Anti-fibrosis heart protecting decoction Download PDFInfo
- Publication number
- CN105434589A CN105434589A CN201511025893.6A CN201511025893A CN105434589A CN 105434589 A CN105434589 A CN 105434589A CN 201511025893 A CN201511025893 A CN 201511025893A CN 105434589 A CN105434589 A CN 105434589A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention provides a traditional Chinese medicine preparation for treating dilated cardiomyopathy and belongs to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine preparation comprises raw materials in parts by weight as follows: 8-12 parts of vinegar turtle shells, 18-22 parts of danshen roots, 18-22 parts of fired peach kernels, 18-22 parts of milkvetch roots, 18-22 parts of Chinese angelica, 18-22 parts of red peony roots, 18-22 parts of vinegar tortoise plastron, 18-22 parts of suberect spatholobus stems, 18-22 parts of lightyellow sophora roots, 18-22 parts of liquorice and 18-22 parts of loofah sponge. The traditional Chinese medicine preparation has the functions of qi enrichment, blood circulation activation, blood stasis dispersing, collateral dredging and anti-fibrosis, has good clinical treatment effects on various syndromes caused by qi deficiency, blood stasis, abnormal qi-blood circulation and meridian blockage, can remarkably improve symptoms of pale and dark purple tongue nature, thin and white tongue coating and deep and hesitant pulse, and has good clinical treatment effects on patients with various syndromes such as lassitude, deficient breath, laziness to speak, palpitation, chest distress and the like caused by dilated cardiomyopathy and cardiac failure.
Description
Technical field
The invention belongs to the technical field of Chinese medicine preparation, relate to the myocardiac Chinese medicine preparation for the treatment of, be specifically related to a kind of Chinese medicine preparation-anti-fibre for the treatment of dilated cardiomyopathy and protect heart soup.
Background technology
Dilated cardiomyopathy is with cardiac dilatation, heart failure, and arrhythmia is main manifestations.Cardiac dilatation is the most common, apex decreased loudness of first sound, due to relative mitral insufficiency, the apex of the heart often has systolic murmur, apex audible opens phase noise once in a while, when heart failure increases the weight of, noise strengthens, and when heart failure alleviates, noise weakens or disappears, about 75% patient's audible third heart sound or fourth heart sound.10% patients' blood increases, may to increase water pool stream relevant with Secretion of Catecholamine during heart failure.After heart failure controls, blood pressure recovers normal, also has and deposits hypertension patient.The person that heart failure occurs, available heart tonifying, diuretic, as systolic pressure is not less than 12.7kpa (95mmHg) available vasodilation.There is arrhythmia person, can according to different arrhythmia, select medication, blood pressure is on the low side person, can intravenous drip dopamine 5ug/min.Clinical symptoms can not be improved and biopsy turns out to be myocarditic patient, can try out the immunosuppressant of a course for the treatment of.The course of disease is short, and onset has heating person, also can use hormone therapy.This patient cardiac muscle Rd is lowered, and along with increasing the weight of of degree of heart failure, lowers also more obvious.In order to improve myocardium Rd, improve the reactivity of cardiac muscle, available blockers treatment.Once generation heart failure, prognosis mala, 5 annual death rate 35%, 10 annual death rate 70%.
Dilated cardiomyopathy forms serious threat to the sound development of the mankind already, current every country all drops into a large amount of manpowers and fund, Therapy study is carried out to heart disease, but the main mode with Western medicine is treated at present, and these Western medicine exist toxic and side effects, cannot eliminate symptom completely, and the dependency of Western medicine is strong, long-term taking, can produce drug resistance, causes therapeutic effect to decline on original basis.
Summary of the invention
The present invention is that to solve in prior art the effect for the treatment of dilated cardiomyopathy bad, and toxic and side effects is large, the problem that easily produces drug resistance, provides a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy.
The present invention is the technical scheme realizing the employing of its object:
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8-12 part, Radix Salviae Miltiorrhizae 18-22 part, Semen Persicae (parched) 18-22 part, Radix Astragali 18-22 part, Radix Angelicae Sinensis 18-22 part, Radix Paeoniae Rubra 18-22 part, vinegar Carapax et Plastrum Testudinis 18-22 part, Caulis Spatholobi 18-22 part, Radix Sophorae Flavescentis 18-22 part, Radix Glycyrrhizae 18-22 part, Retinervus Luffae Fructus 18-22 part.
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 9-11 part, Radix Salviae Miltiorrhizae 19-21 part, Semen Persicae (parched) 19-21 part, Radix Astragali 19-21 part, Radix Angelicae Sinensis 19-21 part, Radix Paeoniae Rubra 19-21 part, vinegar Carapax et Plastrum Testudinis 19-21 part, Caulis Spatholobi 19-21 part, Radix Sophorae Flavescentis 19-21 part, Radix Glycyrrhizae 19-21 part, Retinervus Luffae Fructus 19-21 part.
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8 parts, Radix Salviae Miltiorrhizae 18 parts, Semen Persicae (parched) 18 parts, the Radix Astragali 18 parts, Radix Angelicae Sinensis 18 parts, Radix Paeoniae Rubra 18 parts, vinegar Carapax et Plastrum Testudinis 18 parts, Caulis Spatholobi 18 parts, Radix Sophorae Flavescentis 18 parts, 18 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 18 parts.
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 10 parts, Radix Salviae Miltiorrhizae 20 parts, Semen Persicae (parched) 20 parts, the Radix Astragali 20 parts, Radix Angelicae Sinensis 20 parts, Radix Paeoniae Rubra 20 parts, vinegar Carapax et Plastrum Testudinis 20 parts, Caulis Spatholobi 20 parts, Radix Sophorae Flavescentis 20 parts, 20 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 20 parts.
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 12 parts, Radix Salviae Miltiorrhizae 22 parts, Semen Persicae (parched) 22 parts, the Radix Astragali 22 parts, Radix Angelicae Sinensis 22 parts, Radix Paeoniae Rubra 22 parts, vinegar Carapax et Plastrum Testudinis 22 parts, Caulis Spatholobi 22 parts, Radix Sophorae Flavescentis 22 parts, 22 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 22 parts.
The invention has the beneficial effects as follows:
Benefiting QI for activating blood circulation, disperse blood stasis and dredge collateral, anti-fibre, to blood stasis due to qi deficiency, QI-blood circulation is not normal, and venation caused various syndromes of being obstructed have good clinical therapeutic efficacy, obviously can improve pale tongue or purple dark, thin white fur of tongue, the symptom of deep and hesitant pulse.And have good clinical therapeutic efficacy to the body caused by dilated cardiomyopathy, heart failure tired weak, deficiency of QI with disinclination to talk, cardiopalmus, the various patient such as uncomfortable in chest.
In this Chinese medicine preparation, the mechanism of action of each raw material is: Radix Astragali QI invigorating, and Fuzheng Kang is evil.Carapax Trionycis (processed with vinegar), Radix Salviae Miltiorrhizae, Semen Persicae (parched), Radix Angelicae Sinensis, Radix Paeoniae Rubra, vinegar Carapax et Plastrum Testudinis, Caulis Spatholobi, Retinervus Luffae Fructus activating blood circulation to dissipate blood stasis and dredge the collateral, improve myocardium of dilated Cardiomyopathy fibrosis.Radix Sophorae Flavescentis heat clearing and damp drying, arrhythmia, Radix Sophorae Flavescentis alkaloid has blood vessel dilating and the protective effect to acute myocardial ischemia, Radix Glycyrrhizae QI invigorating strengthening the spleen, coordinating the actions of various ingredients in a prescription.
Meanwhile, Carapax Trionycis (processed with vinegar), vinegar Carapax et Plastrum Testudinis can suppress fibroplasia stimulating factor; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Semen Persicae (parched) obviously can suppress the propagation of cardiac muscle fiber; The Radix Astragali, Radix Angelicae Sinensis suppress Cardiac myocytes, type III collagen protein to generate, and promote the DNA synthesis of myocardial cell, reduce the paraplasm of injury of myocardium.
Chinese medicine preparation of the present invention is a close set compound that can not be split, every Herba indigoferae Pseudotinctoriae all plays vital effect in the composition, every Herba indigoferae Pseudotinctoriae complements each other, not only play respective effect and also promote the performance of other drug effects and the suppression of side effect, this is the long-term result summed up, its respective consumption decides the drug effect of whole medicament, this Chinese medicine preparation is from liver, spleen, stomach, start with in lung four aspect, wherein Carapax Trionycis (processed with vinegar) and vinegar Carapax et Plastrum Testudinis are first fried in the preparation, be conducive to the aminoacid in Carapax Trionycis (processed with vinegar) like this, oligopeptides compound and trace element overflow, conveniently combine with the flavonoid in the Radix Astragali and soaping agents, to the nucleic acid in body, hormone, cell plays a part stable and activates, be aided with Radix Angelicae Sinensis and urge it, blood vessel dilating and the protective effect to acute myocardial ischemia is played under the effect of Radix Sophorae Flavescentis alkaloid, wherein the consumption of each composition decides the performance of drug effect, only in strict accordance with the consumption competence exertion drug effect of this Chinese medicine preparation, otherwise drug effect not only can be caused to decline, serious meeting causes invalid even side effect to damage body health and life security.
Detailed description of the invention
The present invention is that to solve in prior art the effect for the treatment of dilated cardiomyopathy bad, toxic and side effects problem that is large, easily generation drug resistance, provide a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy, this Chinese medicine preparation is taken symptom two days later and is obviously improved and alleviate, adhere to taking and can not produce drug resistance, and therapeutic effect is good, better with other drug conbined usage effect, faster, below in conjunction with specific embodiment, the present invention is further illustrated.
Embodiment 1
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8 parts, Radix Salviae Miltiorrhizae 18 parts, Semen Persicae (parched) 18 parts, the Radix Astragali 18 parts, Radix Angelicae Sinensis 18 parts, Radix Paeoniae Rubra 18 parts, vinegar Carapax et Plastrum Testudinis 18 parts, Caulis Spatholobi 18 parts, Radix Sophorae Flavescentis 18 parts, 18 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 18 parts.
Embodiment 2
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 10 parts, Radix Salviae Miltiorrhizae 20 parts, Semen Persicae (parched) 20 parts, the Radix Astragali 20 parts, Radix Angelicae Sinensis 20 parts, Radix Paeoniae Rubra 20 parts, vinegar Carapax et Plastrum Testudinis 20 parts, Caulis Spatholobi 20 parts, Radix Sophorae Flavescentis 20 parts, 20 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 20 parts.
Embodiment 3
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 12 parts, Radix Salviae Miltiorrhizae 22 parts, Semen Persicae (parched) 22 parts, the Radix Astragali 22 parts, Radix Angelicae Sinensis 22 parts, Radix Paeoniae Rubra 22 parts, vinegar Carapax et Plastrum Testudinis 22 parts, Caulis Spatholobi 22 parts, Radix Sophorae Flavescentis 22 parts, 22 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 22 parts.
Embodiment 4
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 9 parts, Radix Salviae Miltiorrhizae 19 parts, Semen Persicae (parched) 19 parts, the Radix Astragali 19 parts, Radix Angelicae Sinensis 19 parts, Radix Paeoniae Rubra 19 parts, vinegar Carapax et Plastrum Testudinis 19 parts, Caulis Spatholobi 19 parts, Radix Sophorae Flavescentis 19 parts, 19 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 19 parts.
Embodiment 5
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 11 parts, Radix Salviae Miltiorrhizae 21 parts, Semen Persicae (parched) 21 parts, the Radix Astragali 21 parts, Radix Angelicae Sinensis 21 parts, Radix Paeoniae Rubra 21 parts, vinegar Carapax et Plastrum Testudinis 21 parts, Caulis Spatholobi 21 parts, Radix Sophorae Flavescentis 21 parts, 21 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 21 parts.
Embodiment 6
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8.5 parts, Radix Salviae Miltiorrhizae 18.5 parts, Semen Persicae (parched) 18.5 parts, the Radix Astragali 18.5 parts, Radix Angelicae Sinensis 18.5 parts, Radix Paeoniae Rubra 18.5 parts, vinegar Carapax et Plastrum Testudinis 18.5 parts, Caulis Spatholobi 18.5 parts, Radix Sophorae Flavescentis 18.5 parts, 18.5 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 18.5 parts.
Embodiment 7
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 9.5 parts, Radix Salviae Miltiorrhizae 19.5 parts, Semen Persicae (parched) 19.5 parts, the Radix Astragali 19.5 parts, Radix Angelicae Sinensis 19.5 parts, Radix Paeoniae Rubra 19.5 parts, vinegar Carapax et Plastrum Testudinis 19.5 parts, Caulis Spatholobi 19.5 parts, Radix Sophorae Flavescentis 19.5 parts, 19.5 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 19.5 parts.
Embodiment 8
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 10.5 parts, Radix Salviae Miltiorrhizae 20.5 parts, Semen Persicae (parched) 20.5 parts, the Radix Astragali 20.5 parts, Radix Angelicae Sinensis 20.5 parts, Radix Paeoniae Rubra 20.5 parts, vinegar Carapax et Plastrum Testudinis 20.5 parts, Caulis Spatholobi 20.5 parts, Radix Sophorae Flavescentis 20.5 parts, 20.5 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 20.5 parts.
Embodiment 9
Treat a Chinese medicine preparation for dilated cardiomyopathy, described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 110.5 parts, Radix Salviae Miltiorrhizae 21.5 parts, Semen Persicae (parched) 21.5 parts, the Radix Astragali 21.5 parts, Radix Angelicae Sinensis 21.5 parts, Radix Paeoniae Rubra 21.5 parts, vinegar Carapax et Plastrum Testudinis 21.5 parts, Caulis Spatholobi 21.5 parts, Radix Sophorae Flavescentis 21.5 parts, 21.5 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 21.5 parts.
This Chinese medicine preparation in the preparation, first Carapax Trionycis (processed with vinegar), vinegar Carapax et Plastrum Testudinis in side are separated with other medicines, each component drug first soaks 30 minutes, Carapax Trionycis (processed with vinegar), vinegar Carapax et Plastrum Testudinis are decocted first half an hour, then drop into other medicines to continue to decoct, the time of boiling medicine is 2 hours altogether, and temperature reaches 120 DEG C, boil medicine 50 pairs for every pot, add water 25 liters.
Above-mentioned Chinese medicine preparation is through clinical experiment, good clinical therapeutic efficacy is had to the body caused by dilated cardiomyopathy, heart failure tired weak, deficiency of QI with disinclination to talk, cardiopalmus, various patient uncomfortable in chest, after taking, 1 hour uncomfortable in chest, cardiopalmus be improved significantly, after 1 day, weak situation be improved significantly, after 2 days above-mentioned symptom all be improved significantly, the state that basic arrival does not show effect, adheres to taking, therapeutic effect is obvious, and conditions of patients is significantly treated.
Claims (5)
1. treat a Chinese medicine preparation for dilated cardiomyopathy, it is characterized in that: described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8-12 part, Radix Salviae Miltiorrhizae 18-22 part, Semen Persicae (parched) 18-22 part, Radix Astragali 18-22 part, Radix Angelicae Sinensis 18-22 part, Radix Paeoniae Rubra 18-22 part, vinegar Carapax et Plastrum Testudinis 18-22 part, Caulis Spatholobi 18-22 part, Radix Sophorae Flavescentis 18-22 part, Radix Glycyrrhizae 18-22 part, Retinervus Luffae Fructus 18-22 part.
2. a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy according to claim 1, is characterized in that: described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 9-11 part, Radix Salviae Miltiorrhizae 19-21 part, Semen Persicae (parched) 19-21 part, Radix Astragali 19-21 part, Radix Angelicae Sinensis 19-21 part, Radix Paeoniae Rubra 19-21 part, vinegar Carapax et Plastrum Testudinis 19-21 part, Caulis Spatholobi 19-21 part, Radix Sophorae Flavescentis 19-21 part, Radix Glycyrrhizae 19-21 part, Retinervus Luffae Fructus 19-21 part.
3. a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy according to claim 1, is characterized in that: described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 8 parts, Radix Salviae Miltiorrhizae 18 parts, Semen Persicae (parched) 18 parts, the Radix Astragali 18 parts, Radix Angelicae Sinensis 18 parts, Radix Paeoniae Rubra 18 parts, vinegar Carapax et Plastrum Testudinis 18 parts, Caulis Spatholobi 18 parts, Radix Sophorae Flavescentis 18 parts, 18 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 18 parts.
4. a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy according to claim 1, is characterized in that: described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 10 parts, Radix Salviae Miltiorrhizae 20 parts, Semen Persicae (parched) 20 parts, the Radix Astragali 20 parts, Radix Angelicae Sinensis 20 parts, Radix Paeoniae Rubra 20 parts, vinegar Carapax et Plastrum Testudinis 20 parts, Caulis Spatholobi 20 parts, Radix Sophorae Flavescentis 20 parts, 20 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 20 parts.
5. a kind of Chinese medicine preparation for the treatment of dilated cardiomyopathy according to claim 1, is characterized in that: described Chinese medicine preparation is made up of the raw material of following portions by weight: Carapax Trionycis (processed with vinegar) 12 parts, Radix Salviae Miltiorrhizae 22 parts, Semen Persicae (parched) 22 parts, the Radix Astragali 22 parts, Radix Angelicae Sinensis 22 parts, Radix Paeoniae Rubra 22 parts, vinegar Carapax et Plastrum Testudinis 22 parts, Caulis Spatholobi 22 parts, Radix Sophorae Flavescentis 22 parts, 22 parts, Radix Glycyrrhizae, Retinervus Luffae Fructus 22 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511025893.6A CN105434589A (en) | 2015-12-31 | 2015-12-31 | Anti-fibrosis heart protecting decoction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511025893.6A CN105434589A (en) | 2015-12-31 | 2015-12-31 | Anti-fibrosis heart protecting decoction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105434589A true CN105434589A (en) | 2016-03-30 |
Family
ID=55545520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511025893.6A Pending CN105434589A (en) | 2015-12-31 | 2015-12-31 | Anti-fibrosis heart protecting decoction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105434589A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048895A (en) * | 2011-01-17 | 2011-05-11 | 王仁平 | Pure traditional Chinese medicine preparation for treating dilated cardiomyopathy |
| CN103405540A (en) * | 2013-08-28 | 2013-11-27 | 陈宏志 | Traditional Chinese medicine preparation for treating blood stasis |
| CN104338073A (en) * | 2014-09-29 | 2015-02-11 | 李中昕 | Traditional Chinese medicinal preparation for treating dilated cardiomyopathy and preparation method of fluid extract thereof |
-
2015
- 2015-12-31 CN CN201511025893.6A patent/CN105434589A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048895A (en) * | 2011-01-17 | 2011-05-11 | 王仁平 | Pure traditional Chinese medicine preparation for treating dilated cardiomyopathy |
| CN103405540A (en) * | 2013-08-28 | 2013-11-27 | 陈宏志 | Traditional Chinese medicine preparation for treating blood stasis |
| CN104338073A (en) * | 2014-09-29 | 2015-02-11 | 李中昕 | Traditional Chinese medicinal preparation for treating dilated cardiomyopathy and preparation method of fluid extract thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
| CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN111671864A (en) | Traditional Chinese medicine preparation for relieving bone marrow suppression caused by chemotherapy and preparation method thereof | |
| CN106880826A (en) | A kind of Chinese medicine preparation of chronic heart failure and preparation method thereof | |
| CN103463409A (en) | Traditional Chinese medicine formula for treating heart qi deficiency | |
| CN105456428A (en) | Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof | |
| CN101077353B (en) | Cardiac and cerebral vascular disease treating medicine | |
| CN101450106A (en) | Traditional Chinese medicine composition with ischemic myocardium angiogenesis promoting function | |
| CN105434589A (en) | Anti-fibrosis heart protecting decoction | |
| CN103393909B (en) | Chinese medicinal preparation for treating biliary calculus with cholecystitis | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN101579507B (en) | Medicine for treating gall stones and preparation method thereof | |
| CN108653543A (en) | A kind of pharmaceutical composition for treating coronary heart disease | |
| CN104117020A (en) | Traditional Chinese medicinal formula for treating atrial fibrillation | |
| CN107693621A (en) | Chinese medicine and its preparation for coronary heart disease myocardial infarction treatment | |
| CN108704064A (en) | A kind of Chinese medicine composition and preparation method for treating AIDS | |
| CN113679781B (en) | Traditional Chinese medicine composition for treating tachyarrhythmia and preparation method and application thereof | |
| CN105456502A (en) | Traditional Chinese medicine preparation for treating myocarditis | |
| CN105012655A (en) | Traditional Chinese medicinal composition for treating dilated cardiomyopathy and preparation method thereof | |
| CN102228522B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN104147386A (en) | Traditional Chinese medicinal preparation for treating migraine and preparation method thereof | |
| CN104013940A (en) | Traditional Chinese medicine for fumigation foot bath to treat insomnia | |
| CN103816388A (en) | Formula and preparation method of traditional Chinese medicine capable of treating myelosuppression caused by radiotherapy and chemotherapy | |
| CN104383025B (en) | Traditional Chinese medicine for treating chronic rheumatic heart diseases | |
| CN103830629B (en) | Yellow stuff drops in clearing damp |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160330 |